Do Corticosteroid Injections for the Treatment of Pain Influence the Efficacy of mRNA COVID-19 Vaccines?

Myth: Corticosteroid injection for the treatment of pain and inflammation is known to decrease the efficacy of the messenger ribonucleic acid (mRNA)-vaccines for COVID-19.

Learn about the facts surrounding this myth and the best practices to support safe performance of interventional pain procedures in your practice. 

Each participant will read the FactFinder and will answer post-test questions to earn continuing medical education (CME) credits.    

Authors
Haewon Lee, MD; Jennifer A. Punt, A.B., VMD, PhD; David C. Miller, MD, MA; Ameet Nagpal, MD, MS, MEd; Clark C. Smith, MD, MPH; Yusef Sayeed, MD, MPH, MEng; Jaymin Patel, MD; Milan P. Stojanovic, MD; Adrian Popescu, MD; and Zachary L. McCormick, MD, on behalf of the Spine Intervention Society’s Patient Safety Committee

Copyright   
Materials presented in this activity have been made available by the Spine Intervention Society for educational purposes only. We reserve all rights to such material.

Educational Objectives
Upon completion of this activity, participants should be able to:

• Identify best practices to ensure patient safety during interventional pain procedures.
• Cite the evidentiary basis for risk mitigation strategies in the safe performance of interventional pain procedures.

Planner/Author Disclosures
None of the planners or authors had any relevant financial relationships with commercial interests, as determined by the SIS CME Committee. 

References
References are provided within the FactFinder.

Accreditation Statement    
The Spine Intervention Society (SIS) is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.    

Credit Designation Statement    
SIS designates this enduring material for a maximum of 0.5 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.    

Date of Activity Release: 2/5/2021   
Date of Activity Expiration: 2/4/2024